Kulasingam V, Diamandis EP: Strategies for discovering novel cancer biomarkers through utilization of emerging technologies. Nat Clin Pract Oncol. 2008, 5: 588-599.
Article
CAS
PubMed
Google Scholar
Rustin GJ, van der Burg ME, Griffin CL, Guthrie D, Lamont A, Jayson GC, Kristensen G, Mediola C, Coens C, Qian W, Parmar MK, Swart AM, MRC OV05; EORTC 55955 investigators: Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial. Lancet. 2010, 376: 1155-1163. 10.1016/S0140-6736(10)61268-8.
Article
PubMed
Google Scholar
Van Calsteren K, Heyns L, De Smet F, Van Eycken L, Gziri MM, Van Gemert W, Halaska M, Vergote I, Ottevanger N, Amant F: Cancer during pregnancy: an analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes. J Clin Oncol. 2010, 28: 683-689. 10.1200/JCO.2009.23.2801.
Article
PubMed
Google Scholar
Stensheim H, Moller B, van DT, Fossa SD: Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study. J Clin Oncol. 2009, 27: 45-51. 10.1200/JCO.2009.23.8683.
Article
PubMed
Google Scholar
Stensheim H, Cvancarova M, Moller B, Fossa SD: Pregnancy after adolescent and adult cancer: a population-based matched cohort study. Int J Cancer. 2011, 129: 1225-1236. 10.1002/ijc.26045.
Article
CAS
PubMed
Google Scholar
Touitou Y, Darbois Y, Bogdan A, Auzeby A, Keusseoglou S: Tumour marker antigens during menses and pregnancy. Br J Cancer. 1989, 60: 419-420. 10.1038/bjc.1989.297.
Article
CAS
PubMed
PubMed Central
Google Scholar
Schlageter MH, Larghero J, Cassinat B, Toubert ME, Borschneck C, Rain JD: Serum carcinoembryonic antigen, cancer antigen 125, cancer antigen 15-3, squamous cell carcinoma, and tumor-associated trypsin inhibitor concentrations during healthy pregnancy. Clin Chem. 1998, 44: 1995-1998.
CAS
PubMed
Google Scholar
Botsis D, Sarandakou A, Kassanos D, Kontoravdis A, Rizos D, Protonotariou E, Phocas I, Creatsas G: Breast cancer markers during normal pregnancy. Anticancer Res. 1999, 19: 3539-3541.
CAS
PubMed
Google Scholar
Cheli CD, Morris DL, Neaman IE, Dai J, Allard WJ, Yeung KK: Measurement of four tumor marker antigens in the sera of pregnant women. J Clin Lab Anal. 1999, 13: 35-39. 10.1002/(SICI)1098-2825(1999)13:1<35::AID-JCLA7>3.0.CO;2-R.
Article
CAS
PubMed
Google Scholar
Bon GG, Kenemans P, Verstraeten AA, Go S, Philipi PA, van Kamp GJ, van Geijn HP, van Vugt JM: Maternal serum Ca125 and Ca15-3 antigen levels in normal and pathological pregnancy. Fetal Diagn Ther. 2001, 16: 166-172. 10.1159/000053903.
Article
CAS
PubMed
Google Scholar
Ercan S, Kaymaz O, Yucel N, Orcun A: Serum concentrations of CA 125, CA 15-3, CA 19-9 and CEA in normal pregnancy: a longitudinal study. Arch Gynecol Obstet. 2012, 285: 579-584. 10.1007/s00404-011-2025-4.
Article
CAS
PubMed
Google Scholar
Niloff JM, Knapp RC, Schaetzl E, Reynolds C, Bast RC: CA125 antigen levels in obstetric and gynecologic patients. Obstet Gynecol. 1984, 64: 703-707.
CAS
PubMed
Google Scholar
Haga Y, Sakamoto K, Egami H, Yoshimura R, Akagi M: Evaluation of serum CA125 values in healthy individuals and pregnant women. Am J Med Sci. 1986, 292: 25-29. 10.1097/00000441-198607000-00005.
Article
CAS
PubMed
Google Scholar
Jacobs IJ, Fay TN, Stabile I, Bridges JE, Oram DH, Grudzinskas JG: The distribution of CA 125 in the reproductive tract of pregnant and non-pregnant women. Br J Obstet Gynaecol. 1988, 95: 1190-1194. 10.1111/j.1471-0528.1988.tb06798.x.
Article
CAS
PubMed
Google Scholar
Kobayashi F, Sagawa N, Nakamura K, Nonogaki M, Ban C, Fujii S, Mori T: Mechanism and clinical significance of elevated CA 125 levels in the sera of pregnant women. Am J Obstet Gynecol. 1989, 160: 563-566.
Article
CAS
PubMed
Google Scholar
Touitou Y, Bogdan A, Darbois Y: CA-125 ovarian cancer associated antigen in cancer and pregnancy: interpretation of enzyme immunoassay and immunoradiometric assay. Anticancer Res. 1989, 9: 1805-1807.
CAS
PubMed
Google Scholar
Kenemans P, Bon GG, Kessler AC, Verstraeten AA, van Kamp GJ: Multicenter technical and clinical evaluation of a fully automated enzyme immunoassay for CA 125. Clin Chem. 1992, 38: 1466-1471.
CAS
PubMed
Google Scholar
Spitzer M, Kaushal N, Benjamin F: Maternal CA-125 levels in pregnancy and the puerperium. J Reprod Med. 1998, 43: 387-392.
CAS
PubMed
Google Scholar
Petraglia F, Luisi S, Benedetto C, Zonca M, Florio P, Casarosa E, Volpe A, Bernasconi S, Genazzani AR: Changes of dimeric inhibin B levels in maternal serum throughout healthy gestation and in women with gestational diseases. J Clin Endocrinol Metab. 1997, 82: 2991-2995. 10.1210/jc.82.9.2991.
CAS
PubMed
Google Scholar
Fowler PA, Evans LW, Groome NP, Templeton A, Knight PG: A longitudinal study of maternal serum inhibin-A, inhibin-B, activin-A, activin-AB, pro-alphaC and follistatin during pregnancy. Hum Reprod. 1998, 13: 3530-3536. 10.1093/humrep/13.12.3530.
Article
CAS
PubMed
Google Scholar
Wallace EM, Riley SC, Crossley JA, Ritoe SC, Horne A, Shade M, Groome NP: Dimeric inhibins in amniotic fluid, maternal serum, and fetal serum in human pregnancy. J Clin Endocrinol Metab. 1997, 82: 218-222. 10.1210/jc.82.1.218.
CAS
PubMed
Google Scholar
La Marca A, Giulini S, Orvieto R, De L, Volpe A: Anti-Mullerian hormone concentrations in maternal serum during pregnancy. Hum Reprod. 2005, 20: 1569-1572. 10.1093/humrep/deh819.
Article
CAS
PubMed
Google Scholar
Nelson SM, Stewart F, Fleming R, Freeman DJ: Longitudinal assessment of antimullerian hormone during pregnancy-relationship with maternal adiposity, insulin, and adiponectin. Fertil Steril. 2010, 93: 1356-1358. 10.1016/j.fertnstert.2009.07.1676.
Article
CAS
PubMed
Google Scholar
Lutterodt M, Byskov AG, Skouby SO, Tabor A, Yding AC: Anti-Mullerian hormone in pregnant women in relation to other hormones, fetal sex and in circulation of second trimester fetuses. Reprod Biomed Online. 2009, 18: 694-699. 10.1016/S1472-6483(10)60016-8.
Article
PubMed
Google Scholar
van Buul EJ, Steegers EA, Jongsma HW, Eskes TK, Thomas CM, Hein PR: Haematological and biochemical profile of uncomplicated pregnancy in nulliparous women; a longitudinal study. Neth J Med. 1995, 46: 73-85. 10.1016/0300-2977(94)00104-H.
Article
CAS
PubMed
Google Scholar
He S, Bremme K, Kallner A, Blomback M: Increased concentrations of lactate dehydrogenase in pregnancy with preeclampsia: a predictor for the birth of small-for-gestational-age infants. Gynecol Obstet Invest. 1995, 39: 234-238. 10.1159/000292417.
Article
CAS
PubMed
Google Scholar
Larsson A, Palm M, Hansson LO, Axelsson O: Reference values for clinical chemistry tests during normal pregnancy. BJOG. 2008, 115: 874-881. 10.1111/j.1471-0528.2008.01709.x.
Article
CAS
PubMed
Google Scholar
Makkonen M, Penttila IM, Castren O: Serum lactic acid dehydrogenase and isoenzymes during pregnancy and labor. Acta Obstet Gynecol Scand. 1980, 59: 97-102. 10.3109/00016348009154622.
Article
CAS
PubMed
Google Scholar
Fiegler P, Katz M, Kaminski K, Rudol G: Clinical value of a single serum CA-125 level in women with symptoms of imminent abortion during the first trimester of pregnancy. J Reprod Med. 2003, 48: 982-988.
PubMed
Google Scholar
Abbassi-Ghanavati M, Greer LG, Cunningham FG: Pregnancy and laboratory studies: a reference table for clinicians. Obstet Gynecol. 2009, 114: 1326-1331. 10.1097/AOG.0b013e3181c2bde8.
Article
CAS
PubMed
Google Scholar
Hayes DF, Zurawski VR, Kufe DW: Comparison of circulating CA15-3 and carcinoembryonic antigen levels in patients with breast cancer. J Clin Oncol. 1986, 4: 1542-1550.
CAS
PubMed
Google Scholar
Lelle RJ, Henkel E, Leinemann D, Goeschen K: Measurement of CEA, TPA, neopterin, CA125, CA153 and CA199 in sera of pregnant women, umbilical cord blood and amniotic fluid. Gynecol Obstet Invest. 1989, 27: 137-142. 10.1159/000293641.
Article
CAS
PubMed
Google Scholar
Tayyar M, Tutus A: The effect of maternal age, parity, and fetal sex on the amniotic fluid and maternal serum levels of CA 125, CA 19.9, CA 15.3, and CEA. Int J Fertil Womens Med. 1999, 44: 256-259.
CAS
PubMed
Google Scholar
Kiran G, Kiran H, Guler FI, Ekerbicer HC, Kilinc M: Maternal serum and umbilical cord tumor marker levels at term pregnancy. Acta Obstet Gynecol Scand. 2005, 84: 85-89.
Article
PubMed
Google Scholar
Sarandakou A, Protonotariou E, Rizos D: Tumor markers in biological fluids associated with pregnancy. Crit Rev Clin Lab Sci. 2007, 44: 151-178. 10.1080/10408360601003143.
Article
CAS
PubMed
Google Scholar
Shyu MK, Lin MC, Liu CH, Fu YR, Shih JC, Lee CN, Chen HY, Huang J, Huang MC, Hsieh FJ: MUC1 expression is increased during human placental development and suppresses trophoblast-like cell invasion in vitro. Biol Reprod. 2008, 79: 233-239. 10.1095/biolreprod.108.067629.
Article
CAS
PubMed
Google Scholar
Scholz C, Hermann C, Kachler A, Kainer F, Friese K, Makrigiannakis A, et al: Association of placental inflammation with fetomaternal hemorrhage and loss of placental mucin-1. Arch Gynecol Obstet. 2012, 285: 605-612. 10.1007/s00404-011-2028-1.
Article
PubMed
Google Scholar
Crombach G, Scharl A, Vierbuchen M, Wurz H, Bolte A: Detection of squamous cell carcinoma antigen in normal squamous epithelia and in squamous cell carcinomas of the uterine cervix. Cancer. 1989, 63: 1337-1342. 10.1002/1097-0142(19890401)63:7<1337::AID-CNCR2820630719>3.0.CO;2-J.
Article
CAS
PubMed
Google Scholar
Sarandakou A, Kontoravdis A, Kontogeorgi Z, Rizos D, Phocas I: Expression of CEA, CA-125 and SCC antigen by biological fluids associated with pregnancy. Eur J Obstet Gynecol Reprod Biol. 1992, 44: 215-220. 10.1016/0028-2243(92)90102-5.
Article
CAS
PubMed
Google Scholar
Takeshima N, Suminami Y, Takeda O, Abe H, Kato H: Origin of CA125 and SCC antigen in human amniotic fluid. Asia Oceania J Obstet Gynaecol. 1993, 19: 199-204.
Article
CAS
PubMed
Google Scholar
Bast RC, Xu FJ, Yu YH, Barnhill S, Zhang Z, Mills GB: CA 125: the past and the future. Int J Biol Markers. 1998, 13: 179-187.
CAS
PubMed
Google Scholar
Kobayashi F, Sagawa N, Nanbu Y, Nakamura K, Nonogaki M, Ban C, Fujii S, Mori T: Immunohistochemical localization and tissue levels of tumor-associated glycoproteins CA 125 and CA 19-9 in the decidua and fetal membranes at various gestational ages. Am J Obstet Gynecol. 1989, 160: 1232-1238.
Article
CAS
PubMed
Google Scholar
Aggarwal P, Kehoe S: Ovarian tumours in pregnancy: a literature review. Eur J Obstet Gynecol Reprod Biol. 2011, 155: 119-124. 10.1016/j.ejogrb.2010.11.023.
Article
PubMed
Google Scholar
Timmerman D, Ameye L, Fischerova D, Epstein E, Melis GB, Guerriero S, van Holsbeke C, Savelli L, Fruscio R, Lissoni AA, Testa AC, Veldman J, Vergote I, Van Huffel S, Bourne T, Valentin L: Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA group. BMJ. 2010, 341: c6839-10.1136/bmj.c6839.
Article
PubMed
PubMed Central
Google Scholar
Geerts I, Vergote I, Neven P, Billen J: The role of inhibins B and antimullerian hormone for diagnosis and follow-up of granulosa cell tumors. Int J Gynecol Cancer. 2009, 19: 847-855. 10.1111/IGC.0b013e3181a702d1.
Article
PubMed
Google Scholar
Bingle L, Singleton V, Bingle CD: The putative ovarian tumour marker gene HE4 (WFDC2), is expressed in normal tissues and undergoes complex alternative splicing to yield multiple protein isoforms. Oncogene. 2002, 21: 2768-2773. 10.1038/sj.onc.1205363.
Article
CAS
PubMed
Google Scholar
Hellstrom I, Raycraft J, Hayden-Ledbetter M, Ledbetter JA, Schummer M, McIntosh M, Drescher C, Urban N, Hellström KE: The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma. Cancer Res. 2003, 63: 3695-3700.
PubMed
Google Scholar
Moore RG, Brown AK, Miller MC, Skates S, Allard WJ, Verch T, Steinhoff M, Messerlian G, DiSilvestro P, Granai CO, Bast RC: The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass. Gynecol Oncol. 2008, 108: 402-408. 10.1016/j.ygyno.2007.10.017.
Article
CAS
PubMed
Google Scholar
Van Gorp T, Cadron I, Despierre E, Daemen A, Leunen K, Amant F, Timmerman D, De Moor B, Vergote I: HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm. Br J Cancer. 2011, 104: 863-870. 10.1038/sj.bjc.6606092.
Article
CAS
PubMed
PubMed Central
Google Scholar
Huhtinen K, Suvitie P, Hiissa J, Junnila J, Huvila J, Kujari H, Setälä M, Härkki P, Jalkanen J, Fraser J, Mäkinen J, Auranen A, Poutanen M, Perheentupa A: Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts. Br J Cancer. 2009, 100: 1315-1319. 10.1038/sj.bjc.6605011.
Article
CAS
PubMed
PubMed Central
Google Scholar
Montz FJ, Horenstein J, Platt LD, d'Ablaing G, Schlaerth JB, Cunningham G: The diagnosis of immature teratoma by maternal serum alpha-fetoprotein screening. Obstet Gynecol. 1989, 73: 522-525.
CAS
PubMed
Google Scholar
Wisser J, Florio I, Neff M, Konig V, Huch R, Huch A, von Mandach U: Changes in bone density and metabolism in pregnancy. Acta Obstet Gynecol Scand. 2005, 84: 349-354.
Article
PubMed
Google Scholar